Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Citalopram (Generic Health) TM
Active ingredients: citalopram
On February 26, 2019 Citalopram (Generic Health) was not listed on the Australian Register of Therapeutic Goods (ARTG).
Healthdirect medicine data is refreshed once a month, see Data sources page. The medicine you searched for may have been added to the ARTG after this date.
Ask your pharmacist, doctor or health professional for advice, or search the ARTG.
Is this medicine available in Australia?
The ARTG is the register of all therapeutic goods that can be lawfully supplied in Australia. Sometimes a special provision is made to make available some medicines that are not listed in response to the needs of particular people or circumstances. To find out more check out the "Access to therapeutic goods not on the ARTG" section on the ARTG page.
Other medicines that contain: citalopram
Need more information?
These trusted information partners have more on this topic.
Top results
Selective serotonin reuptake inhibitors (SSRIs) for depression - myDr.com.au
Selective serotonin reuptake inhibitors (SSRIs) are medicines used to treatdepression and anxiety. In fact, they are the most commonly prescribed type of antidepressant medicine in Australia.&nb
Read more on myDr website
How To Deal With Depression and Sadness | THIS WAY UP
Unexplained or overwhelming sadness can be a symptom of depression. Learn more about depression, its causes, and ways to get better.
Read more on This Way Up website
How To Deal with Panic Attacks and Agoraphobia | THIS WAY UP
Feeling overwhelmed by panic? You may be dealing with panic attacks, panic disorder, or agoraphobia. Learn more about these conditions.
Read more on This Way Up website
Top results
Selective serotonin reuptake inhibitors (SSRIs) for fibromyalgia | Cochrane
Researchers of the Cochrane Collaboration conducted a review of research about the effects of antidepressants classified as serotonin reuptake inhibitors (SSRIs) on fibromyalgia. After searching for all relevant studies up to June 2014, they found seven studies that compared SSRIs with a fake medication. These studies included a total of 383 people. Most participants were middle-aged women. The SSRIs that they studied were citalopram, fluoxetine and paroxetine. Five studies were each funded by pharmaceutical companies, and two studies were funded by public institutions.
Read more on Cochrane (Australasian Centre) website
Drugs in breastfeeding | Issue 5 | Volume 38 | Australian Prescriber
Most commonly used drugs are relatively safe for breastfed babies. The dose received via milk is generally small and much less than the known safe doses of...
Read more on Australian Prescriber website
Antidepressants for agitation and psychosis in dementia | Cochrane
Psychosis and agitation frequently occur in older adults with dementia. Medications are often prescribed to treat these symptoms and antidepressants are increasingly used for these symptoms. We reviewed the evidence for the effectiveness and safety of antidepressants for the treatment of agitation and psychosis in older adults with dementia. We classified antidepressants based on their mechanism of action and included studies that compared antidepressants to treatment with either placebo or other medications frequently used to manage these symptoms. A total of nine studies (including 692 individuals) were identified, four comparing selective serotonin reuptake inhibitors (SSRIs) to placebo, three comparing SSRIs to typical antipsychotics, and one study comparing SSRIs to atypical antipsychotics. One study compared the antidepressant trazodone to placebo, and two compared trazodone to haloperidol. Most of the studies included in the review were relatively small and of uncertain risk of bias due to methodological issues. The SSRIs sertraline and citalopram were associated with a modest reduction in symptoms of agitation and psychosis when compared to placebo in two studies. There were few other statistically significant differences in changes in agitation or psychosis or in most measures of medication tolerability for SSRIs or trazodone when compared to placebo or the antipsychotic haloperidol. We conclude that there is some evidence to support the use of certain antidepressants for agitation and psychosis in dementia and further studies are required to determine the effectiveness and safety of SSRIs and trazodone in managing these symptoms.
Read more on Cochrane (Australasian Centre) website
Managing obsessive compulsive disorder | Issue 4 | Volume 38 | Australian Prescriber
Unlike obsessive compulsive personality traits or occasional repetitive habits, obsessive compulsive disorder can be highly distressing and associated with...
Read more on Australian Prescriber website
Clinicians FAQ | THIS WAY UP
Do you have questions about This Way Up, and how it works? Find all the answers to our Frequently Asked Questions.
Read more on This Way Up website
Depression
Depression is a mood state that is characterised by significantly lowered mood and a loss of interest or pleasure in activities that are normally enjoyable. Such depressed mood is a common and normal experience in the population. However, a major depressive episode can be distinguished from this `normal’ depression by its severity, persistence, duration, and the presence of characteristic symptoms (e.g., sleep disturbances).
Read more on CRUfAD – Clinical Research Unit for Anxiety and Depression website
Switching and stopping antidepressants | Issue 3 | Volume 39 | Australian Prescriber
Switching people from one antidepressant to another is commonly needed but can cause drug withdrawal symptoms, drug interactions and relapse in depression....
Read more on Australian Prescriber website
Risk assessment of drug-induced QT prolongation | Issue 1 | Volume 38 | Australian Prescriber
Drugs can cause prolongation of the QT interval, alone or in combination, potentially leading to fatal arrhythmias such as torsades de pointes. When...
Read more on Australian Prescriber website
Population pharmacokinetics: an overview | Issue 6 | Volume 37 | Australian Prescriber
The pharmacokinetics of a drug refers to how it is handled by the body. This includes absorption, distribution, metabolism and elimination. Pharmacokinetic...
Read more on Australian Prescriber website
NonHormonal Treatments for Menopausal Symptoms - Australasian Menopause Society
Many women request non-hormonal treatments for menopausal symptoms. This information sheet addresses the evidence concerning safety and efficacy of currently available non-hormonal treatments for menopausal symptoms
Read more on Australasian Menopause Society website
